Product Information
OCTREOTIDE ACET 50 MCG/ML VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $2.6422 per ML under NDC 00641617410. Its NADAC has been published 110 times since May 22, 2024.
Strength
50 ug/mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00641617410
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Last Updated
4/22/2026
Active Ingredients
OCTREOTIDE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA076313On Market Since
4/4/2005
Pharmacological Classes
Price Statistics
The NADAC for OCTREOTIDE ACET 50 MCG/ML VIAL has been published 110 times since May 22, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.6422 per ML |
|---|---|
| All-time high | $2.9314 (Jul 10, 2024) |
| All-time low | $2.2252 (Sep 18, 2024) |
| 52-week high | $2.6422 |
| 52-week low | $2.6216 |
| Median price | $2.6216 |
| Average price | $2.5885 |
| Largest weekly change | -15.2% (Sep 18, 2024) |
| Weeks tracked | 110 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Octreotide Acetate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OCTREOTIDE ACET 50 MCG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for OCTREOTIDE ACET 50 MCG/ML VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $2.6422 per ML (NDC 00641617410), effective Jun 24, 2026.
How has the price of OCTREOTIDE ACET 50 MCG/ML VIAL changed over time?
Over the history we have for it, the NADAC for OCTREOTIDE ACET 50 MCG/ML VIAL has held within roughly two percent of its current level. It has been tracked across 110 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for OCTREOTIDE ACET 50 MCG/ML VIAL?
Since May 22, 2024, the NADAC for OCTREOTIDE ACET 50 MCG/ML VIAL has ranged from a low of $2.2252 (Sep 18, 2024) to a high of $2.9314 (Jul 10, 2024), with a median of $2.6216 per ML.
Are there cheaper alternatives to OCTREOTIDE ACET 50 MCG/ML VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OCTREOTIDE ACET 50 MCG/ML VIAL, so no direct lower-cost alternative is listed.
Who manufactures OCTREOTIDE ACET 50 MCG/ML VIAL?
OCTREOTIDE ACET 50 MCG/ML VIAL (NDC 00641617410) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification